Cargando…

Alterations of consciousness and mystical-type experiences after acute LSD in humans

RATIONALE: Lysergic acid diethylamide (LSD) is used recreationally and in clinical research. Acute mystical-type experiences that are acutely induced by hallucinogens are thought to contribute to their potential therapeutic effects. However, no data have been reported on LSD-induced mystical experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Liechti, Matthias E., Dolder, Patrick C., Schmid, Yasmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420386/
https://www.ncbi.nlm.nih.gov/pubmed/27714429
http://dx.doi.org/10.1007/s00213-016-4453-0
_version_ 1783234387315261440
author Liechti, Matthias E.
Dolder, Patrick C.
Schmid, Yasmin
author_facet Liechti, Matthias E.
Dolder, Patrick C.
Schmid, Yasmin
author_sort Liechti, Matthias E.
collection PubMed
description RATIONALE: Lysergic acid diethylamide (LSD) is used recreationally and in clinical research. Acute mystical-type experiences that are acutely induced by hallucinogens are thought to contribute to their potential therapeutic effects. However, no data have been reported on LSD-induced mystical experiences and their relationship to alterations of consciousness. Additionally, LSD dose- and concentration-response functions with regard to alterations of consciousness are lacking. METHODS: We conducted two placebo-controlled, double-blind, cross-over studies using oral administration of 100 and 200 μg LSD in 24 and 16 subjects, respectively. Acute effects of LSD were assessed using the 5 Dimensions of Altered States of Consciousness (5D-ASC) scale after both doses and the Mystical Experience Questionnaire (MEQ) after 200 μg. RESULTS: On the MEQ, 200 μg LSD induced mystical experiences that were comparable to those in patients who underwent LSD-assisted psychotherapy but were fewer than those reported for psilocybin in healthy subjects or patients. On the 5D-ASC scale, LSD produced higher ratings of blissful state, insightfulness, and changed meaning of percepts after 200 μg compared with 100 μg. Plasma levels of LSD were not positively correlated with its effects, with the exception of ego dissolution at 100 μg. CONCLUSIONS: Mystical-type experiences were infrequent after LSD, possibly because of the set and setting used in the present study. LSD may produce greater or different alterations of consciousness at 200 μg (i.e., a dose that is currently used in psychotherapy in Switzerland) compared with 100 μg (i.e., a dose used in imaging studies). Ego dissolution may reflect plasma levels of LSD, whereas more robustly induced effects of LSD may not result in such associations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00213-016-4453-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5420386
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-54203862017-05-22 Alterations of consciousness and mystical-type experiences after acute LSD in humans Liechti, Matthias E. Dolder, Patrick C. Schmid, Yasmin Psychopharmacology (Berl) Original Investigation RATIONALE: Lysergic acid diethylamide (LSD) is used recreationally and in clinical research. Acute mystical-type experiences that are acutely induced by hallucinogens are thought to contribute to their potential therapeutic effects. However, no data have been reported on LSD-induced mystical experiences and their relationship to alterations of consciousness. Additionally, LSD dose- and concentration-response functions with regard to alterations of consciousness are lacking. METHODS: We conducted two placebo-controlled, double-blind, cross-over studies using oral administration of 100 and 200 μg LSD in 24 and 16 subjects, respectively. Acute effects of LSD were assessed using the 5 Dimensions of Altered States of Consciousness (5D-ASC) scale after both doses and the Mystical Experience Questionnaire (MEQ) after 200 μg. RESULTS: On the MEQ, 200 μg LSD induced mystical experiences that were comparable to those in patients who underwent LSD-assisted psychotherapy but were fewer than those reported for psilocybin in healthy subjects or patients. On the 5D-ASC scale, LSD produced higher ratings of blissful state, insightfulness, and changed meaning of percepts after 200 μg compared with 100 μg. Plasma levels of LSD were not positively correlated with its effects, with the exception of ego dissolution at 100 μg. CONCLUSIONS: Mystical-type experiences were infrequent after LSD, possibly because of the set and setting used in the present study. LSD may produce greater or different alterations of consciousness at 200 μg (i.e., a dose that is currently used in psychotherapy in Switzerland) compared with 100 μg (i.e., a dose used in imaging studies). Ego dissolution may reflect plasma levels of LSD, whereas more robustly induced effects of LSD may not result in such associations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00213-016-4453-0) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-10-07 2017 /pmc/articles/PMC5420386/ /pubmed/27714429 http://dx.doi.org/10.1007/s00213-016-4453-0 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Investigation
Liechti, Matthias E.
Dolder, Patrick C.
Schmid, Yasmin
Alterations of consciousness and mystical-type experiences after acute LSD in humans
title Alterations of consciousness and mystical-type experiences after acute LSD in humans
title_full Alterations of consciousness and mystical-type experiences after acute LSD in humans
title_fullStr Alterations of consciousness and mystical-type experiences after acute LSD in humans
title_full_unstemmed Alterations of consciousness and mystical-type experiences after acute LSD in humans
title_short Alterations of consciousness and mystical-type experiences after acute LSD in humans
title_sort alterations of consciousness and mystical-type experiences after acute lsd in humans
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420386/
https://www.ncbi.nlm.nih.gov/pubmed/27714429
http://dx.doi.org/10.1007/s00213-016-4453-0
work_keys_str_mv AT liechtimatthiase alterationsofconsciousnessandmysticaltypeexperiencesafteracutelsdinhumans
AT dolderpatrickc alterationsofconsciousnessandmysticaltypeexperiencesafteracutelsdinhumans
AT schmidyasmin alterationsofconsciousnessandmysticaltypeexperiencesafteracutelsdinhumans